Journal
CELL DEATH & DISEASE
Volume 13, Issue 7, Pages -Publisher
SPRINGERNATURE
DOI: 10.1038/s41419-022-05090-3
Keywords
-
Categories
Funding
- National Nature Science Foundation of China [82000808, 81902857]
Ask authors/readers for more resources
This study reveals a novel regulatory mechanism of prostate cancer AR inhibitor resistance, showing that GDF15 plays a role in this resistance and its N70 glycosylation is involved in relieving the inhibitory effect on the EGFR pathway. Interfering with GDF15 or the EGFR pathway can reduce the survival of resistant cells and tumor growth.
Castration-resistance of prostate cancer is one of the most challenging clinical problems. In the present study, we have performed proteomics and glycomics using LNCaP model. Growth differentiation factor-15 (GDF15) level is increased in androgen receptor (AR) inhibitor-resistant cells and the inhibitory effect of GDF15 on epithelial growth factor receptor (EGFR) pathway is relieved by GDF15 N70 glycosylation. Interference of GDF15 (siRNA or N70Q dominant negative) or EGFR pathway (inhibitor or siRNA for EGFR, SRC or ERK) decreases the resistant-cell survival in culture and tumor growth in mice. Our study reveals a novel regulatory mechanism of prostate cancer AR inhibitor resistance, raises the possibility of AR/SRC dual-targeting of castration-resistance of prostate cancer, and lays foundation for the future development of selective inhibitors of GDF15 glycosylation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available